Comment Hmmmm. (Score 2) 52
I don't criticise the concept, but the concern is whether it has long-term adverse neurological effects, and a "quick study" doesn't sound like it'll tell us that.
It's essential we have more ways of dealing with treatment-resistant depression. We just need to make sure that they're less harmful than the depression itself. You willl, of course, recall that each and every single bad decision by medical boards to approve a treatment has been because they wanted to rush through a "medical cure" that turned into a medical hell.
I'm not stupid enough to say that mushrooms would cause long-term damage, but equally I'm not stupid enough to say that we should only look to see if it has short-term benefits.
The correct approach would seem to be to make sure there aren't any immediate hazards and, if there aren't, then to continue the study to check for consequences of long-term use whilst authorising short-term prescription use, on the understanding that the prescription use permission will be extended outwards to whatever the data cansafely tolerate. In other words, don't deprive people of necessary treatment but equally don't claim greater confidence than the data supports.
This tightrope has only got to be walked because nobody has been seriously studying depression for a very long time and now we've got a hunge backlog of cases that are refusing to shut up, making it hard to ignore. This research should have been done years ago, but politicians were far too ignorant and far too swayed by religious money. But that doesn't mean we should rush.
I'm sure the scientists know how to keep a level head, but the CEOs and the politicians clearly can't and they're the ones who will be making the demands.